amphetamines - CISMeF

Preferred Label : amphetamines;

MeSH definition : Analogs or derivatives of AMPHETAMINE. Many are sympathomimetics and central nervous system stimulators causing excitation, vasopressin, bronchodilation, and to varying degrees, anorexia, analepsis, nasal decongestion, and some smooth muscle relaxation.;

Wikipedia automatic translation : Substituted phenethylamine;

MeSH annotation : GEN or unspecified; prefer specifics; do not confuse with AMPHETAMINE, a specific chem; N-methylamphetamine METHAMPHETAMINE; general or unspecified; prefer specifics; do not confuse with AMPHETAMINE, a specific chemical;

Wikipedia link : https://en.wikipedia.org/wiki/Substituted phenethylamine;

Codes EINECS : 206-096-2;

Is substance : O;

Details

Origin ID

D000662;

UMLS CUI

C0002667;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Amfetamine [ICHI extension code]
- Amphetamine Sulfate [NCIt concept]
- Amphetamines [HPMULTI term]
- Amphetamines tested for [LOINC component]
- Dextroamphetamine [NCIt concept]
- Methamphetamine [LOINC component]
- club drugs [MedlinePlus Topic]
- l-amphetamine [Substance BNPC]
- methamphetamine [MedlinePlus Topic]
Currated CISMeF NLP mapping
- Amphetamines [LOINC component]
Indexing information
- amphetamine receptor [MeSH Supplementary Concept]
MeSH Descriptor(s) used for indexing
- amphetamine [MeSH Descriptor]
MedlinePlus topic(s)
- club drugs [MedlinePlus Topic]
- methamphetamine [MedlinePlus Topic]
Record concept(s)
- amphetamines [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1-(2,5-dimethyl-4-iodophenyl)-2-aminopropane [MeSH Supplementary Concept]
- 1-(4-ethylphenyl-)-N-((2-methoxyphenyl)methyl) propane-2-amine [MeSH Supplementary Concept]
- 1-(4-methylphenyl)propane-2-amine [MeSH Supplementary Concept]
- 2,4,5-trihydroxyamphetamine [MeSH Supplementary Concept]
- 2,4,5-trimethoxyamphetamine [MeSH Supplementary Concept]
- 2,4,5-trimethoxyphenylisopropylamine [MeSH Supplementary Concept]
- 2,4-dimethoxy-N,N-dimethyl-5-iodophenylisopropylamine [MeSH Supplementary Concept]
- 2,4-dimethoxy-N,N-dimethylphenylisopropylamine [MeSH Supplementary Concept]
- 2,5-dimethoxy-3-nitroamphetamine [MeSH Supplementary Concept]
- 2,5-dimethoxy-N,N-dimethyl-4-iodoamphetamine [MeSH Supplementary Concept]
- 2,5-dimethoxyamphetamine [MeSH Supplementary Concept]
- 2-(4-hydroxy-3-iodophenyl)-N,N,N-trimethylethanaminium [MeSH Supplementary Concept]
- 2-amino-3-fluoro-1-phenylpropane [MeSH Supplementary Concept]
- 2-chloroamphetamine [MeSH Supplementary Concept]
- 2-ethylamino-1-phenyl-propan-1-one [MeSH Supplementary Concept]
- 2-methylamphetamine [MeSH Supplementary Concept]
- 3,4-dihydroxyethylamphetamine [MeSH Supplementary Concept]
- 3,4-dimethoxyamphetamine [MeSH Supplementary Concept]
- 3-methoxyamphetamine [MeSH Supplementary Concept]
- 3-methylamphetamine [MeSH Supplementary Concept]
- 4-chloro-beta,beta-difluoroamphetamine [MeSH Supplementary Concept]
- 4-ethoxyamphetamine [MeSH Supplementary Concept]
- 4-fluoroamphetamine [MeSH Supplementary Concept]
- 4-hydroxy-3-methoxyethylamphetamine [MeSH Supplementary Concept]
- 4-hydroxyclobenzorex [MeSH Supplementary Concept]
- 4-hydroxyethylamphetamine [MeSH Supplementary Concept]
- 4-iodo-2,5-dimethoxyphenylisopropylamine [MeSH Supplementary Concept]
- 4-iodoamphetamine [MeSH Supplementary Concept]
- 4-methoxy-N-butylamphetamine [MeSH Supplementary Concept]
- 4-methoxy-N-ethylamphetamine [MeSH Supplementary Concept]
- 4-methoxyamphetamine [MeSH Supplementary Concept]
- 4-methyl-alpha-ethyl-m-tyramine [MeSH Supplementary Concept]
- 4-methylethcathinone [MeSH Supplementary Concept]
- 4-methylthioamphetamine [MeSH Supplementary Concept]
- IEM 1365 [MeSH Supplementary Concept]
- IEM 1370 [MeSH Supplementary Concept]
- IEM 570 [MeSH Supplementary Concept]
- N,N-dimethylcathinone [MeSH Supplementary Concept]
- N-(2-dansylaminoethyl)amphetamine [MeSH Supplementary Concept]
- N-acetylamphetamine [MeSH Supplementary Concept]
- N-cyanomethylmethamphetamine [MeSH Supplementary Concept]
- N-desmethylmethoxyphenamine [MeSH Supplementary Concept]
- N-ethyl-4-methoxyamphetamine [MeSH Supplementary Concept]
- N-hydroxyamphetamine [MeSH Supplementary Concept]
- N-methyl-N-propyl amphetamine [MeSH Supplementary Concept]
- SLI381 [MeSH Supplementary Concept]
- adamantylamphetamine [MeSH Supplementary Concept]
- adderall [MeSH Supplementary Concept]
- amphetamine hydroxylamine [MeSH Supplementary Concept]
- amphetamine, pGlu-His- [MeSH Supplementary Concept]
- amphetaminil [MeSH Supplementary Concept]
- anfepramone [MeSH Supplementary Concept]
- beta,beta-difluoroamphetamine [MeSH Supplementary Concept]
- beta-methylphenyl-ethylamine [MeSH Supplementary Concept]
- bis(1-thio-2-amino-3-phenylpropane) [MeSH Supplementary Concept]
- carmoterol [MeSH Supplementary Concept]
- clobenzorex [MeSH Supplementary Concept]
- desmethylselegiline [MeSH Supplementary Concept]
- di(beta-phenylisopropyl)amine [MeSH Supplementary Concept]
- ethylamphetamine [MeSH Supplementary Concept]
- fenethylline [MeSH Supplementary Concept]
- fenproporex [MeSH Supplementary Concept]
- fepracet [MeSH Supplementary Concept]
- formetamide [MeSH Supplementary Concept]
- mefenorex [MeSH Supplementary Concept]
- p-fluoro-L-amphetamine [MeSH Supplementary Concept]
- pGlu-His-Pro-amphetamine [MeSH Supplementary Concept]
- pentylone [MeSH Supplementary Concept]
- phenpentermine [MeSH Supplementary Concept]
- pseudoephenamine [MeSH Supplementary Concept]
- ruthenocene-N-isopropylamphetamine [MeSH Supplementary Concept]
See also
- adrenergic uptake inhibitors [MeSH Descriptor]
- appetite depressants [MeSH Descriptor]
- central nervous system stimulants [MeSH Descriptor]
See also (suggested by CISMeF)
- amphetamine-related disorders [MeSH Descriptor]
See also inter- (CISMeF)
- Amphetamine Drug Class Measurement [NCIt concept]
- Amphetamine Measurement [NCIt concept]
- Amphetamine measurement (procedure) [SNOMED CT concept]
- Amphetamines [MedDRA Preferred Term]
- Product containing amfetamine (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Biologically Active Substance [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Amphetamines [LOINC component]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients